Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 1997 Apr;50(4):328-31.
doi: 10.1136/jcp.50.4.328.

The hormonal receptor status of uterine carcinosarcomas (mixed müllerian tumours): an immunohistochemical study

A C Ansink  1 , P A Cross, P Scorer, A de Barros Lopes, J M Monaghan
Affiliations

The hormonal receptor status of uterine carcinosarcomas (mixed müllerian tumours): an immunohistochemical study

A C Ansink et al. J Clin Pathol. 1997 Apr.

Abstract

Aim: To investigate the role of oestrogen and progesterone receptor status in uterine carcinosarcomas (mixed Müllerian tumours) to see whether the receptors were identifiable, and if so whether they were of significance clinically.

Methods: 11 cases of uterine carcinosarcoma were identified from clinical and pathology records. An immunohistochemical method was used to demonstrate oestrogen and progesterone hormone receptors on paraffin embedded material, with suitable tissue controls, staining being recorded.

Results: 10 of 11 cases showed staining for one or both hormone receptors in normal tissue adjacent to tumour. In four carcinosarcoma cases, staining for one or both receptors was shown within the epithelial component (appearing to correlate with the degree of epithelial differentiation); two of these cases had staining within sarcomatous areas. Two of the three patients still alive had epithelial hormone receptor positivity.

Conclusions: Receptors for oestrogen and progesterone were found in four of 11 cases of uterine carcinosarcoma, using paraffin embedded material. There may be an association between hormone receptor positivity and clinical outcome.

PubMed Disclaimer

References

    1. Gynecol Oncol. 1987 Jan;26(1):87-97 - PubMed
    1. Gynecol Oncol. 1990 Dec;39(3):364-7 - PubMed
    1. Obstet Gynecol. 1986 Mar;67(3):417-24 - PubMed
    1. Gynecol Oncol. 1990 May;37(2):268-75 - PubMed
    1. Int J Gynecol Pathol. 1994 Apr;13(2):127-30 - PubMed

Publication types

Substances